KIRSTEN RUTH: Open Payments
NPI 1033831581 · APO, AE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 41 payments from 19 companies in 2025. Trend: 2023 $317 · 2024 $1,144 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $217 |
| SANOFI-AVENTIS U.S. LLC | 2 | $51 |
| Lilly USA, LLC | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| PFIZER INC. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| ABBVIE INC. | 2 | $35 |
| Grifols USA, LLC | 1 | $28 |
| IntraBio Inc | 1 | $26 |
Products named: Rybelsus, Wegovy, TZIELD, Kerendia, SHINGRIX, Ozempic, GARDASIL 9, QULIPTA.
Industry payments across AE — which companies pay providers there.
